Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

$MRK - $UNVC CBD JV speculation running rampant

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mikeyt1818 Member Profile
 
Followed By 75
Posts 3,816
Boards Moderated 0
Alias Born 07/29/17
160x600 placeholder
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:25:26 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:23:46 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:22:15 PM
Merck Hosts 2019 Investor Day Outlining Bus. Momentum, Strong Expected Growth & Focus on Innovative Research & Development Business Wire - 6/20/2019 6:45:00 AM
Merck Seeks Deals As It Expands Its Cancer Treatments -- WSJ Dow Jones News - 6/20/2019 3:02:00 AM
AstraZeneca & Merck’s LYNPARZA® (olaparib) Approved in Japan as First-Line Maintenance Therapy in Patients with BRCA-Mutat... Business Wire - 6/19/2019 6:45:00 AM
Merck Seeks More Deals Dow Jones News - 6/19/2019 5:59:00 AM
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Monotherapy for Patients with Metastatic Small Cell Lung Cancer (SCLC) w... Business Wire - 6/18/2019 6:45:00 AM
LYNPARZA® (olaparib) Approved in the EU for Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ova... Business Wire - 6/18/2019 6:30:00 AM
Drug Firms Sue Over Ad Rule -- WSJ Dow Jones News - 6/15/2019 3:02:00 AM
Drugmakers Sue to Block Federal Rule Requiring Drug Prices in TV Ads Dow Jones News - 6/14/2019 6:27:00 PM
IBM, KPMG, Merck and Walmart to collaborate as part of FDA's program to evaluate the use of blockchain to protect pharmaceuti... PR Newswire (US) - 6/13/2019 8:05:00 AM
FDA Approves Two New Indications for Merck’s KEYTRUDA® (pembrolizumab) Business Wire - 6/11/2019 6:45:00 AM
Merck to Buy Tilos Therapeutics for Up to $773 Million Dow Jones News - 6/10/2019 7:37:00 AM
Merck to Acquire Tilos Therapeutics Business Wire - 6/10/2019 6:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:22:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:21:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:21:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:21:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:20:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:20:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:20:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:20:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:19:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:19:11 PM
mikeyt1818   Saturday, 10/27/18 11:20:27 PM
Re: mikeyt1818 post# 387
Post # of 468 
$MRK - $UNVC CBD JV speculation running rampant online. MilliporeSigma patch will be the delivery mechanism. Fits into this newspaper article:

.....Additionally, Merck may be entertaining a spinoff that would give it a prominent foothold in the cannabis processing market.

Your editor Sean McCloskey divulged this info to me, after sitting down to lunch with the Segment Marketing Manager of MillaporeSigma (a division of Merck), at of all places, a marijuana investors conference in Toronto this past August.

Whether we see a pot spinoff from Merck one day is anyone’s guess, but based on the dots we can connect, there’s a betting man’s chance we do.

Since we first suggested Merck in May shares are up over 18%. This even after the market’s broad selloff the past two weeks. Clearly there are strong tailwinds at work.

If their drug Keytruda successfully navigates the final stages of the FDA gauntlet, the gains from this revenue stream should help boost shares.

And if my suspicions are correct that a Merck is planning a cannabis spinoff venture, their shares could really run higher.


Ray Blanco (TechProfitsDaily@p.sevenfigurepublishing.com)


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist